| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
H3 histone pseudogene 40 | 0.506 | 0.846 |
|
group | 0.100 | None | 1.000 | 10 | 0 | 2005 | 2020 | |||||||||
|
microRNA 137 | 0.513 | 0.846 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2013 | 2018 | |||||||||
|
POTE ankyrin domain family member K, pseudogene | 0.542 | 0.769 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2002 | 2018 | |||||||||
|
centralopathic epilepsy | 0.626 | 0.423 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | |||||||||
|
long intergenic non-protein coding RNA 273 | 0.585 | 0.846 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2017 | |||||||||
|
chromosome 20 open reading frame 181 | 0.479 | 0.885 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
schizophrenia 13 | 0.931 | 0.038 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
long intergenic non-protein coding RNA 1602 |
|
group | 0.100 | None | 1.000 | 1 | 2 | 2010 | 2010 | |||||||||||
|
SAA2-SAA4 readthrough |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | |||||||||||
|
NALCN antisense RNA 1 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | |||||||||||
|
HLA complex group 9 | 0.700 | 0.500 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
LINC02210-CRHR1 readthrough | 0.570 | 0.692 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
serotonin transporter intronic VNTR enhancer | 0.636 | 0.538 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | |||||||||
|
CUB and Sushi multiple domains 2 | 0.695 | 0.269 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
H3 histone pseudogene 19 | 0.631 | 0.577 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | |||||||||
|
idiopathic basal ganglia calcification 1 | 0.861 | 0.154 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
disrupted in schizophrenia 2 | 0.716 | 0.192 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | |||||||||
|
long intergenic non-protein coding RNA 243 | 0.729 | 0.423 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||||||
|
microRNA 223 | 0.433 | 0.808 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | |||||||||
|
microRNA 338 | 0.535 | 0.808 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
NADH dehydrogenase, subunit 4 (complex I) | 0.546 | 0.769 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
NADH dehydrogenase, subunit 5 (complex I) | 0.531 | 0.769 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
serine protease 2 | 0.628 | 0.769 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
ATXN8 opposite strand lncRNA | 0.650 | 0.423 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | |||||||||
|
pericentrin | 0.564 | 0.808 | 4.0E-58 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 |